Bluebird Bio Inc.
13F holders, Q2 2025 (June 30)3holders −82
1new positions
83sold out
$4.95avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Bluebird Bio Inc. in their 13F filings, down 82 from Q1 2025. 1 opened new positions and 83 sold out. The largest holders were Russell Investments Group, Ltd. ($7K), Barclays PLC ($4) and IFP Advisors, Inc ($3).
- Company
- Bluebird Bio Inc.
- CUSIP
- 09609G209
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3 |
| Exits | 83 | $17.1M |
All 13F filers, Q1 2025 → Q2 2025: 1,285 shares bought and 3,501,135 shares sold, net −3,499,850 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Russell Investments Group, Ltd. | 0.00% | Add +1183.3% | 1,386 | $7K |
| Barclays PLC | 0.00% | Reduce -100.0% | 1 | $4 |
| IFP Advisors, Inc | 0.00% | New | 7 | $3 |
"% of holder's portfolio" is BLUEBIRD BIO INC's weight in each manager's 13F, not the share of Bluebird Bio Inc. the manager owns.